Advertisement
Advertisement

MYNZ

MYNZ logo

Mainz Biomed N.V.

6.68
USD
+1.91
+40.04%
Dec 20, 15:59 UTC -5
Closed
...

Mainz Biomed N.V. Profile

About

Mainz Biomed N.V. develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The Company's flagship product is ColoAlert, an accurate, non-invasive, and easy-to-use early detection diagnostic test for colorectal cancer. Mainz Biomed N.V. is based in BERKELEY, Calif.

Info & Links

CEO

Guido Baechler

Headquarters

ROBERT KOCH STRASSE 50
MAINZ, 2M 55129, GERMANY

Auditor

Reliant CPA PC

Share holders

31

Employees

71

Mainz Biomed N.V. Statistics

Valuation Measures

Market Capitalization2

--

Enterprise Value

--

Enterprise Value/EBITDA(ttm)

--

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

10.66

Price to Book(mrq)

0.44

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

41.57%

Operating Margin(ttm)

--

Profit Margin(ttm)

-2126.13%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-304.47%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

646.60K

Revenue Per Share(ttm)

--

Gross Profit(ttm)

360.80K

EBITDA(ttm)3

-18.02M

Net Income Available to Common(ttm)

-18.04M

Diluted EPS(ttm)

-65.60

Share Statistics

Beta (5Y Monthly)

0.06

52-Week Change

-89.50%

S&P 500 52-Week Change

24.21%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

1.64M

% Held by Insiders

18.20%

% Held by Institutions

0.00%

Balance Sheet

Total Cash(mrq)

977.80K

Total Cash Per Share(mrq)

--

Total Debt(mrq)

7.24M

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

--

Quick Ratio(mrq)

0.19%

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

--

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement